Addex Therapeutics (ADXN) EBT Margin (2022 - 2025)
Historic EBT Margin for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to 5306.25%.
- Addex Therapeutics' EBT Margin fell 24688500.0% to 5306.25% in Q3 2025 from the same period last year, while for Sep 2025 it was 5549.1%, marking a year-over-year decrease of 47188800.0%. This contributed to the annual value of 1214.88% for FY2024, which is 10598700.0% down from last year.
- Addex Therapeutics' EBT Margin amounted to 5306.25% in Q3 2025, which was down 24688500.0% from 33612.08% recorded in Q2 2025.
- In the past 5 years, Addex Therapeutics' EBT Margin ranged from a high of 33612.08% in Q2 2025 and a low of 78901.26% during Q4 2024
- Moreover, its 4-year median value for EBT Margin was 1003.29% (2022), whereas its average is 4262.05%.
- Its EBT Margin has fluctuated over the past 5 years, first plummeted by -783160500bps in 2024, then surged by 348788300bps in 2025.
- Quarter analysis of 4 years shows Addex Therapeutics' EBT Margin stood at 1071.63% in 2022, then tumbled by -155bps to 585.21% in 2023, then crashed by -13383bps to 78901.26% in 2024, then soared by 93bps to 5306.25% in 2025.
- Its EBT Margin stands at 5306.25% for Q3 2025, versus 33612.08% for Q2 2025 and 1632.8% for Q1 2025.